A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors
HRYZ Biotech Co.
HRYZ Biotech Co.
Mayo Clinic
NRG Oncology
Gilead Sciences
University of Chicago
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine
Columbia University
Morphotek
Boehringer Ingelheim
National Institutes of Health Clinical Center (CC)
University Health Network, Toronto
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Nevada Cancer Institute